From Mankind Pharma to SBI - Motilal Oswal recommends these stocks | Check targets

ZeeBiz WebTeam | Jun 15, 2024, 11:36 AM IST

5 Stocks to Buy in 2024: The market has been quite unpredictable of late. Amid this volatility, there is also an opportunity to buy quality shares from a long-term perspective. 

1/7

5 Stocks to Buy in 2024

5 Stocks to Buy in 2024

5 Stocks to Buy in 2024: Brokerage house Motilal Oswal has given a 'BUY' rating to these gives stocks with strong fundamentals. This list includes Mankind Pharma, Trent, Home First Finance, CEAT and SBI. 

2/7

5 Stocks to Buy in 2024: Mankind Pharma

5 Stocks to Buy in 2024: Mankind Pharma

5 Stocks to Buy in 2024: Motilal Oswal has given a BUY call on Mankind Pharma with a target of Rs 2,650 per share. On June 13, 2024, the share price closed at Rs 2,235. From here, the stock has the potential of gaining 19 per cent.

3/7

5 Stocks to Buy in 2024: Trent

5 Stocks to Buy in 2024: Trent

5 Stocks to Buy in 2024: The brokerage has advised investors to BUY Trent. The target per share is Rs 5,500. On June 13, 2024, the share closed at Rs 5,030 and therefore has the potential of giving a 10 per cent return.

4/7

5 Stocks to Buy in 2024: Home First Finance

5 Stocks to Buy in 2024: Home First Finance

5 Stocks to Buy in 2024: Motilal Oswal has given a BUY call on Home First Finance with a target per share of Rs 1,080. On June 13, 2024, the counter had closed at Rs 1,025. 

5/7

5 Stocks to Buy in 2024: CEAT

5 Stocks to Buy in 2024: CEAT

5 Stocks to Buy in 2024: Motilal Oswal has given a BUY call on CEAT with a target price of Rs 2930 per share. On June 13, 2024, the share price closed at Rs 2550. 

6/7

5 Stocks to Buy in 2024: SBI

5 Stocks to Buy in 2024: SBI

5 Stocks to Buy in 2024: Motilal Oswal has advised investors to BUY SBI for a target of Rs 1,015. On June 13, 2024, the share price closed at Rs. 844. In this way, the stock may rise by 20 per cent.

7/7

Disclaimer

Disclaimer

The advice to invest in stocks here has been given by the brokerage house. These are not the views of Zee Business. Consult your advisor before investing.

By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.

x